首页> 外文期刊>The Turkish journal of pediatrics >Neonatal hemochromatosis: a case report with unique presentation.
【24h】

Neonatal hemochromatosis: a case report with unique presentation.

机译:新生儿血色素沉着病:病例报告独特。

获取原文
获取原文并翻译 | 示例
           

摘要

Acute liver failure (ALF) is a relatively rare condition in neonates, and early diagnosis and treatment are crucial for the treatable conditions. Neonatal hemochromatosis (NH) is a rare clinical condition that is clinically defined as severe neonatal liver disease associated with hepatic and extrahepatic iron deposition in a distribution similar to that seen in hereditary hemochromatosis. Although a few cases have been reported with spontaneous remission, early and aggressive medical treatment is essential for improving the outcome. Despite aggressive treatment, some patients may require liver transplantation. We report a five-day-old male infant with NH and associated Duarte variant galactosemia, renal tubulopathy and hypertyrosinemia, who was successfully treated with combination medical treatment. Combination therapy may reduce the need for liver transplantation in infants with NH. Early diagnosis and aggressive treatment are important as in galactosemia or tyrosinemia for the outcome. Thus, NH may be listed as a treatable cause of ALF in neonates.
机译:急性肝衰竭(ALF)在新生儿中是相对罕见的疾病,早期诊断和治疗对于可治疗的疾病至关重要。新生儿血色素沉着病(NH)是一种罕见的临床疾病,临床上定义为与肝和肝外铁沉积有关的严重新生儿肝脏疾病,其分布与遗传性血色素沉着病相似。尽管已经报道了一些自发缓解的病例,但是早期和积极的药物治疗对于改善预后至关重要。尽管进行了积极的治疗,但有些患者可能需要进行肝移植。我们报告了一名五天大的男婴,患有NH和相关的Duarte变体半乳糖血症,肾小管病和高酪氨酸血症,已成功通过联合药物治疗。联合治疗可减少NH婴儿的肝移植需求。早期诊断和积极治疗与半乳糖血症或酪氨酸血症一样,对于预后至关重要。因此,NH可能被列为新生儿ALF的可治疗原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号